Akari Therapeutics PLC (AKTX)
0.97
-0.03
(-2.99%)
USD |
NASDAQ |
Dec 20, 16:00
0.95
-0.02
(-2.06%)
After-Hours: 20:00
Akari Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| DBV Technologies SA | 1.211 |
| Ascendis Pharma AS | -- |
| Cellectis SA | 1.245 |
| Adaptimmune Therapeutics PLC | 1.935 |
| Biodexa Pharmaceuticals PLC | 0.2052 |
Price to Book Value Related Metrics
| Price | 0.97 |
| Earnings Yield | -283.7% |
| Market Cap | 24.02M |